Last reviewed · How we verify

NCT06343701

Investigation of Motor Imaging Skills in Children With Spastic Cerebral Palsy

Status unknown Last updated 3 April 2024
What this trial tests

trial testing Implicit motor imagery in Cerebral Palsy, Spastic in 90 participants. Status unknown.

Timeline
18 July 2023
Primary endpoint
5 May 2024
25 June 2024

Quick facts

Lead sponsorAbant Izzet Baysal University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment90
Start date18 July 2023
Primary completion5 May 2024
Estimated completion25 June 2024
Sites3 locations across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Abant Izzet Baysal University

Who can join

Adults 6 to 18, any sex, with Cerebral Palsy, Spastic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to investigate implicit and explicit motor imagery skills in children with spastic cerebral palsy and typically developing children. The main questions it aims to answer are: * There is a difference between the implicit motor imagery skills of children with bilateral and unilateral CP. * There is a difference between the explicit motor imagery skills of children with bilateral and unilateral CP. * There is a difference between the implicit motor imagery skills of children with cerebral palsy and typically developing children. * There is a difference between the explicit motor imagery skills of children with cerebral palsy and typically developing children.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Implicit motor imagery

Trials testing the same drug.

Other recruiting trials for Cerebral Palsy, Spastic

Currently open trials in the same condition.

Other Abant Izzet Baysal University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06343701.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing